Spruce Biosciences logo

Spruce Biosciences Share Price Today

(NASDAQ: SPRB)

Spruce Biosciences share price is $0.36 & ₹31.31 as on 6 Mar 2025, 2.30 'hrs' IST

$0.36

Market is closed - opens 8 PM, 06 Mar 2025

View live Spruce Biosciences share price in Dollar and Rupees. Guide to invest in Spruce Biosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Spruce Biosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Spruce Biosciences share price movements

  • Today's Low: $0.34
    Today's High: $0.37

    Day's Volatility :7.83%

  • 52 Weeks Low: $0.34
    52 Weeks High: $5.95

    52 Weeks Volatility :94.29%

Spruce Biosciences (SPRB) Returns

PeriodSpruce Biosciences IncSector (Health Care)Index (Russel 2000)
3 Months
-27.43%
3.7%
0.0%
6 Months
-21.74%
-2.8%
0.0%
1 Year
-93.08%
2.5%
0.0%
3 Years
-80.89%
12.9%
-11.6%

Spruce Biosciences (SPRB) Key Statistics

in dollars & INR

Previous Close
$0.3573
Open
$0.366
Today's High
$0.3689
Today's Low
$0.34
Market Capitalization
$14.8M
Today's Volume
$130.9K
52 Week High
$5.95
52 Week Low
$0.34
Revenue TTM
$7.1M
EBITDA
$-43.2M
Earnings Per Share (EPS)
$-0.94
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-57.55%

How to invest in Spruce Biosciences Stock (SPRB) from India?

It is very easy for Indian residents to invest directly in Spruce Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Spruce Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Spruce Biosciences or SPRB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Spruce Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Spruce Biosciences shares which would translate to 2.416 fractional shares of Spruce Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Spruce Biosciences, in just a few clicks!

Returns in Spruce Biosciences (SPRB) for Indian investors in Rupees

The Spruce Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Spruce Biosciences investment value today

Current value as on today

₹11,885

Returns

₹88,115

(-88.11%)

Returns from Spruce Biosciences Stock

₹93,064 (-93.06%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Spruce Biosciences (SPRB)

-29%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Spruce Biosciences Stock from India on INDmoney has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Spruce Biosciences

  • RiverVest Venture Management LLC

    7.11%

  • The Carlyle Group Inc

    7.01%

  • Rock Springs Capital Management LP

    6.32%

  • Ikarian Capital, LLC

    2.42%

  • Vanguard Group Inc

    2.04%

  • Sands Capital Ventures, LLC

    1.73%

Analyst Recommendation on Spruce Biosciences

Buy

    53%Buy

    46%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Spruce Biosciences(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
11
Hold
6
6
1
Sell
0
0
0

Analyst Forecast on Spruce Biosciences Stock (SPRB)

What analysts predicted

Upside of 409.25%

Target:

$1.83

Current:

$0.36

Insights on Spruce Biosciences Stock (Ticker Symbol: SPRB)

  • Price Movement

    In the last 1 year, SPRB stock has moved down by -93.1%
  • SPRB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 159.6%
  • SPRB vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 133.6%
  • Price to Sales

    ForSPRB every $1 of sales, investors are willing to pay $2.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Spruce Biosciences Technicals Summary

Sell

Neutral

Buy

Spruce Biosciences is currently in a neutral trading position according to technical analysis indicators.

Spruce Biosciences (SPRB) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Spruce Biosciences Inc logo
-9.5%
-21.74%
-93.08%
-80.89%
-97.89%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Spruce Biosciences Inc logo
NA
NA
NA
-0.93
-0.58
-0.3
NA
1.25
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Spruce Biosciences Inc logo
Buy
$14.8M
-97.89%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Spruce Biosciences

Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction in adult patients with classic CAH that is Phase 2b clinical trial. It is also developing tildacerfont for the treatment of pediatric classic congenital adrenal hyperplasia in children that is in Phase 2 clinical trial; and for females with polycystic ovary syndrome, which is in Phase 2 clinical trial. Spruce Biosciences, Inc. has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses; and collaboration and license agreement with Kaken Pharmaceutical Co. Ltd. to develop, manufacture, and commercialize tildacerfont for the treatment of CAH in Japan. The company was incorporated in 2014 and is headquartered in South San Francisco, California.
Organization
Spruce Biosciences
Employees
22
CEO
Dr. Javier Szwarcberg M.D., M.P.H.
Industry
Commercial Services

Management People of Spruce Biosciences

NameTitle
Mr. Michael G. Grey
Executive Chairman
Dr. Javier Szwarcberg M.D., M.P.H.
CEO & Director
Mr. Samir M. Gharib CPA, M.B.A.
President & CFO
Ms. P. J. Ramtin
Senior Vice President of Business Operations
Ms. Heidi Petersen M.P.H.
Senior Vice President of Regulatory & Quality

Important FAQs about investing in SPRB Stock from India :

What is Spruce Biosciences share price today?

Spruce Biosciences share price today stands at $0.36, Open: $0.37 ; Previous Close: $0.36 ; High: $0.37 ; Low: $0.34 ; 52 Week High: $5.95 ; 52 Week Low: $0.34.

The stock opens at $0.37, after a previous close of $0.36. The stock reached a daily high of $0.37 and a low of $0.34, with a 52-week high of $5.95 and a 52-week low of $0.34.

Can Indians buy Spruce Biosciences shares?

Yes, Indians can invest in the Spruce Biosciences (SPRB) from India.

With INDmoney, you can buy Spruce Biosciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Spruce Biosciences at zero transaction cost.

How can I buy Spruce Biosciences shares from India?

It is very easy to buy Spruce Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Spruce Biosciences (SPRB) be purchased?

Yes, you can buy fractional shares of Spruce Biosciences with INDmoney app.

What are the documents required to start investing in Spruce Biosciences stocks?

To start investing in Spruce Biosciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Spruce Biosciences Stock (SPRB)?

Today’s highest price of Spruce Biosciences (SPRB) is $0.37.

Today’s lowest price of Spruce Biosciences (SPRB) is $0.34.

What is today's market capitalisation of Spruce Biosciences?

Today's market capitalisation of Spruce Biosciences SPRB is 14.8M

What is the 52 Week High and Low Range of Spruce Biosciences Stock (SPRB)?

  • 52 Week High

    $5.95

  • 52 Week Low

    $0.34

What are the historical returns of Spruce Biosciences (SPRB)?

  • 1 Month Returns

    -9.5%

  • 3 Months Returns

    -21.74%

  • 1 Year Returns

    -93.08%

  • 5 Years Returns

    -97.89%

Who is the Chief Executive Officer (CEO) of Spruce Biosciences ?

Dr. Javier Szwarcberg M.D., M.P.H. is the current Chief Executive Officer (CEO) of Spruce Biosciences.